Market closedNon-fractional
Pfizer/PFE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Ticker
PFE
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
New York, United States
Employees
88,000
Website
www.pfizer.com
Pfizer Metrics
BasicAdvanced
$171B
Market cap
-
P/E ratio
-$0.06
EPS
0.63
Beta
$1.65
Dividend rate
5.47%
Dividend yield
Price and volume
Market cap
$171B
Beta
0.63
Dividend rate
$1.65
Financial strength
Current ratio
1.047
Quick ratio
0.67
Long term debt to equity
66.61
Total debt to equity
75.522
Interest coverage (TTM)
1.15%
Management effectiveness
Return on assets (TTM)
0.93%
Return on equity (TTM)
-0.26%
Valuation
Price to revenue (TTM)
3.106
Price to book
1.85
Price to tangible book (TTM)
-4.29
Price to free cash flow (TTM)
33.388
Dividend yield (TTM)
5.47%
Growth
Revenue change (TTM)
-41.08%
Earnings per share change (TTM)
-101.15%
3-year revenue growth (CAGR)
6.00%
3-year earnings per share growth (CAGR)
-68.63%
3-year dividend per share growth (CAGR)
2.55%
What the Analysts think about Pfizer
Analyst Ratings
Majority rating from 26 analysts.
Pfizer Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15B
4.41%
Net income
$3.1B
-192.46%
Profit margin
20.93%
-188.54%
Pfizer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.67
-$0.17
$0.10
$0.82
-
Expected
$0.57
-$0.34
-$0.22
$0.52
$0.45
Surprise
18.02%
-49.39%
-145.84%
56.58%
-
Pfizer News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Sept
3
Pfizer
Dividend·Payment
$0.42
Per share
FAQs
What’s the current market cap for Pfizer stock?
Pfizer (PFE) has a market cap of $171B as of July 27, 2024.
What is the P/E ratio for Pfizer stock?
The price to earnings (P/E) ratio for Pfizer (PFE) stock is 0 as of July 27, 2024.
Does Pfizer stock pay dividends?
Yes, the Pfizer (PFE) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $1.65 and the yield is 5.47%. Pfizer has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Pfizer dividend payment date?
The next Pfizer (PFE) dividend payment is scheduled for September 03, 2024.
What is the beta indicator for Pfizer?
Pfizer (PFE) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Pfizer stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.